Lifetime and actual prevalence of pain and headache in multiple sclerosis

Multiple Sclerosis

Volumn 14, Issue 4, 2008, Pages 514-521

  Boneschi, F Martinelli ^a   Colombo, Bruno ^a   Annovazzi, P ^a   Martinelli, V ^a   Bernasconi, L ^a   Solaro, C ^b   Comi, G ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Department of Neurology   (Italy)

Author keywords

Headache; Multiple sclerosis; Pain; Prevalence

Indexed keywords

AMITRIPTYLINE; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BACLOFEN; BETA1A INTERFERON; CARBAMAZEPINE; CORTICOSTEROID DERIVATIVE; GABAPENTIN; GLATIRAMER; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INTERFERON BETA SERINE; MITOXANTRONE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; ITALY; LIFESPAN; LOW BACK PAIN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MORBIDITY; MULTIPLE SCLEROSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MUSCLE SPASM; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; OUTPATIENT DEPARTMENT; PHYSICAL DISABILITY; PREVALENCE; QUESTIONNAIRE; RECURRENCE RISK; RISK ASSESSMENT; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE; SYMPTOMATOLOGY; TENSION HEADACHE; TRIGEMINUS NEURALGIA;

ADULT; AGE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PAIN; PARESTHESIA; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SPASM; TENSION-TYPE HEADACHE; TRIGEMINAL NEURALGIA;

EID: 46749085037     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458507085551     Document Type: Article

References (35)

1. Charcot, JM. Leçons sur les maladies du Système Nerveux, faites à la Salpêtrière. Delahaye, A, Lecrosnier, A, (eds). Paris: Progres Medicale 1872.
2. Svendsen, KB, Jensen, TS, Hansen, HJ, Bach, FW. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 2005; 114: 473-481.
3. Clifford, DB, Trotter, JL. Pain in multiple sclerosis. Arch Neurol 1984; 41: 1270-1272.
4. Vermote, R, Ketelaer, P, Carlton, H. Pain in multiple sclerosis patients: a prospective study using the McGill pain questionnaire. Clin Neurol Neurosurg 1996; 88: 87-93.
5. Kassirer, MR, Osterberg, DH. Pain in chronic multiple sclerosis. J Pain Symptom Manage 1987; 2: 95-97.
6. Moulin, DE, Foley, KM, Ebers, GC. Pain syndromes in multiple sclerosis. Neurology 1988; 38: 1830-1834.
7. Rolak, LA, Brown, S. Headaches and multiple sclerosis: a clinical study and review of the literature. J Neurol 1990; 237: 300-302.
8. Warnell, P. The pain experience of a multiple sclerosis population: a descriptive study. Axon 1991; 13: 26-28.
9. Stenager, E, Knutsen, L, Jensen, K. Acute and chronic pain syndromes in multiple sclerosis. Acta Neurol Scand 1991; 84: 197-200.
10. Archibald, CJ, McGrath, PJ, Ritvo, PG, Fisk, JD, Bhan, V, Maxner, CE, et al. Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain 1994; 58: 89-93.
11. Indaco, A, Iachetta, C, Nappi, C, Socci, L, Carrieri, PB. Chronic and acute pain syndromes in patients with multiple sclerosis. Acta Neurol 1994; 16: 97-102.
12. Rae-Grant, AD, Eckert, NJ, Bartz, S, Reed, JF. Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity. Mult Scler 1999; 5: 179-183.
13. Ehde, DM, Gibbons, LE, Chwastiak, L, Bombardier, CH, Sullivan, MD, Kraft, GH. Chronic pain in a large community sample of persons with multiple sclerosis. Mult Scler 2003; 9: 605-611.
14. Svendsen, KB, Jensen, TS, Overvad, K, Hansen, HJ, Koch-Henriksen, N, Bach, FW. Pain in patients with multiple sclerosis: a population-based study. Arch Neurol 2003; 60: 1089-1094.
15. Solaro, C, Brichetto, G, Amato, MP, Cocco, E, Colombo, B, D'Aleo, G, et al. The prevalence of pain in multiple sclerosis. A multicenter cross-sectional study. Neurology 2004; 63: 919-921
16. Beiske, AG, Pedersen, ED, Czujko, B, Myhr, KM. Pain and sensory complaints in multiple sclerosis. Eur J Neurol 2004; 11: 479-482.
17. Pollmann, W, Erasmus, LP, Feneberg, W, Then Berg, F, Straube, A. Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology 2002; 59: 636-639.
18. Pollman, W, Feneberg, W, Erasmus, FP. Pain in MS - a still underestimated problem. The 1 year prevalence of pain syndromes, significance and quality of care of multiple sclerosis inpatients. Nervenartz 2004; 75: 135-140.
19. D'Amico, D, La Mantia, L, Rigamonti, A, Usai, S, Mascoli, N, Milanese, C, et al. Prevalence of primary headaches in people with Multiple Sclerosis. Cephalagia 2004; 24: 980-984.
20. D,Aleo G, Rifici C, Sessa E, Di Bella P, Bramanti P. R3 nociceptive reflex in multiple sclerosis patients with paroxysmal symptoms treated with gabapentin. Funct Neurol 2000; 15: 205-209.
21. Sandyk, R. Serotonergic neuronal sprouting as a potential mechanism of recovery in multiple sclerosis. Int J Neurosci 1999; 97: 131-138.
22. Beric, A. Central pain and dysesthesia syndrome. Neurol Clin 1998; 16: 899-918.
23. Boivie, J. Central pain. In Wall, PD, Melzack, R, (eds). Textbook of pain. New York: Churchill Livingstone, 1999; 879-914.
24. Hains, BC, Willis, WD, Hulsebosch, CE. Temporal plasticity of dorsal horn somatosensory neurons after acute and chronic spinal cord hemisection in rat. Brain Res 2003; 970: 238-241.
25. Lenz, FA, Kwan, HC, Martin, R, Tasker, R, Richardson, RT, Dostrovsky, JO. Characteristics of somatotopic organization and spontaneous neuronal activity in the region of the thalamic principal sensory nucleus in patients with spinal cord transection. J Neurophysiol 1994; 72: 1570-1587.
26. Welch, KMA, Nagesh, V, Aurora, SK, Gelman, N. Periaqueductal grey matter dysfunction in migraine: cause or the burden of illness? Headache 2001; 41: 629-637.
27. Knight, YE, Goadsby, PJ. Periaqueductal grey matter modulates trigeminvascular input: a role in migraine. Neuroscience 2001; 106: 793-800.
28. The International Classification of Headache Disorders. Cephalalgia 2004; 24: 8-160.
29. Kurtzke, JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-1452.
30. Lublin, FD, Reingold, SC. The National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-911.
31. Poser, CM, Paty, DW, Scheinberg, L, McDonald, WI, Davis, FA, Ebers, GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
32. McDonald, WI, Compston, A, Edan, G, Goodkin, D, Hartung, HP, Lublin, FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
33. Filippini, G, Munari, L, Incorvaia, B, Ebers, GC, Polman, C, D'Amico, R, et al. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 2003; 361: 545-552.
34. Pollmann, W, Erasmus, LP, Feneberg, W, Straube, A. The effect of glatiramer acetate treatment on pre-existing headaches in patients with MS. Neurology 2006; 66: 275-277.
35. Garcia Moreno, JM, Izquierdo, G. Lhermitte's sign. Neurologia 2002; 17: 143-150.